← Eichor
Study identifier: NCT05329636 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy

Condition: Helicobacter Pylori Infection  ·  Sponsor: Tel-Aviv Sourasky Medical Center

PhasePhase 1/Phase 2
Planned participants30
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

Current guidelines mandate Helicobacter pylori (H. Pylori) eradication with 2-3 antibiotics for 14 days ,This may result in multiple side effects and in eradication of important bacterial species to human health, exposing humans to multiple disease conditions. Preservation of fecal microbiome prior to antibiotic therapy and auto-transplantation of the microbes post H. pylori eradication, will enable avoiding eradication of beneficial microbial populations and perhaps protect from consequent disease conditions.

This description comes directly from the study's public registry record.

Talk to the study team

Nitsan Maharshak, MD  ·  97227360384  ·  nitsanm@tlvmc.gov.il

Rony Izhar, PHD  ·  97237772613  ·  ronyi@tlvmc.gov.il

Always discuss trial participation with your own doctor first.

Locations (1)

Dep. of Gastroenterology, Tel Aviv Sourasky Medical CenterTel Aviv, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05329636